Copyright © Inderes 2011 - present. All rights reserved.
Log ind for at modtage meddelelser.

You seem to be using a wider screen, would you like to enable a wider viewing experience on this page?

  • Latest
  • Markeder
    • Aktieoversigt
    • Finanskalender
    • Research
    • Artikler
  • InderesTV
  • Forum
  • Om os
    • Fulgte selskaber
    • Team

ExpreS2ion Biotechnologies - Rights Issue

Af Michael FriisHead of Equities
ExpreS2ion Biotech Holding

ExpreS2ion Biotechnologies is currently carrying out a rights issue with preferential rights for existing shareholders. If fully subscribed, the rights issue will raise about SEK 102m in cash before costs in the first round, with the potential for an equal amount through a warrant program. Around 50% of the right issue is covered.

In a virtual live event today with CEO Bent Frandsen, we went through details and the plan of the rights issue, among others the use of the proceeds, and the options you have as an investor with preferential rights.

For further information, the prospectus can be found here: https://investor.expres2ionbio.com/wp-content/uploads/2023/03/2023-Rights-Issue-Prospectus-ENG.pdf

HC Andersen Capital receives payment from ExpreS2ion Biotechnologies for a Corporate Visibility/Digital IR subscription agreement. /Michael Friis 17:00, 31 March 2023.

Haypp Group, Capital Markets Day, 2023
28.11.2023 14.00 Haypp Group
Bonesupport, Capital Markets Day, 2023
28.11.2023 13.30 Bonesupport
Curasight - Præsentation af Q3 2023
28.11.2023 13.30 Curasight
DDM Debt, Audiocast with teleconference, Q3, 2023
28.11.2023 10.00 DDM Holding
OrderYOYO – M&A and fifth upgrade of 2023 guidance
27.11.2023 10.00 OrderYOYO
Vis alle videoer
Forbinder investorer og virksomheder

Vores sociale mål er at demokratisere information på de finansielle markeder, så alle har lige muligheder for at investere og spare op til deres egen fremtid.

Tag kontakt
  • mie@hcandersencapital.dk
  • +45 28 74 66 40
  • Bredgade 23B, 2. sal
    1260 København K
  • Om os
  • Servicevilkår
  • Privatlivspolitik
  • Ansvarsfraskrivelse for research
Inderes’ ansvarsfraskrivelse kan findes her. Detaljeret information om hver aktie, der aktivt overvåges af Inderes og HC Andersen Capital, er tilgængelig på de virksomhedsspecifikke sider på Inderes' hjemmeside. © Inderes Oyj. All rights reserved.